# 20/20 Biolabs, Inc. (AIDX) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_fb330e374ced5e54385d · retrieved 2026-08-11T15:59:13.839Z

## Overview
20/20 Biolabs, Inc. is a testing laboratory services company classified under SIC 8734.

On July 16, 2026, 20/20 Biolabs, Inc. entered into a standstill agreement with Streeterville Capital, LLC, a holder of Series E convertible preferred stock issued under a November 17, 2025 securities purchase agreement for up to $40,000,000. Under the standstill, Streeterville agreed to refrain from converting its Series E shares into common stock for 120 days unless the common stock trades at least 10% above the Nasdaq Minimum Price on any given trading day. The standstill terminates immediately upon any breach or Event of Default under the Certificate of Designation. The company also disclosed on July 17, 2026 that it received notice from Nasdaq of non-compliance with the $1.00 minimum bid price rule and has been granted a 180-calendar day compliance period (until January 13, 2027) to regain compliance.

## Terms
- Counterparty: Streeterville Capital, LLC · Deal value: $40.0M · Price/share: $1000

## Key dates
- Announced 2026-07-22 · Expiry 2026-10-14

## Timeline
- 2026-07-22 · 8-K (0001213900-26-080432): 8-K - 20/20 Biolabs, Inc. — *20/20 Biolabs, Inc. is a testing laboratory services company classified under SIC 8734.* On July 16, 2026, 20/20 Biolabs, Inc. entered into a standstill agreement with Streeterville Capital, LLC, a holder of Series E convertible preferred stock issued under a November 17, 2025 securities purchase agreement for up to $40,000,000. Under the standstill, Streeterville agreed to refrain from converting its Series E shares into common stock for 120 days unless the common stock trades at least 10% above the Nasdaq Minimum Price on any given trading day. The standstill terminates immediately upon any breach or Event of Default under the Certificate of Designation. The company also disclosed on July 17, 2026 that it received notice from Nasdaq of non-compliance with the $1.00 minimum bid price rule and has been granted a 180-calendar day compliance period (until January 13, 2027) to regain compliance.
  https://www.sec.gov/Archives/edgar/data/1139685/0001213900-26-080432.txt

## Citations
- 0001213900-26-080432 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026080432